Atlas Trials

The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib:A Prospective, Single-arm, Multicenter, Observational Study

Clinical trial NCT07180459 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07180459
Sponsor
Xuhua Duan
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
CarcinomaHepatocellular Carcinoma
Start date
2025-10-10
Primary completion
2026-10-10
Enrollment
118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.